Neil A Smart1, Mark Waldron, Hashbullah Ismail, Francesco Giallauria, Carlo Vigorito, Veronique Cornelissen, Gudrun Dieberg. 1. 1University of New England, School of Science and Technology, Armidale, New South Wales, Australia 2Department of Translational Medical Sciences, Division of Internal Medicine and Cardiac Rehabilitation, Federico II University of Naples, Naples, Italy 3University of Leuven, KU Leuven, Department of Rehabilitation Sciences, Leuven, Belgium.
Abstract
INTRODUCTION: Several established tools are available to assess study quality and reporting of randomized controlled trials; however, these tools were designed with clinical intervention trials in mind. In exercise training intervention trials some of the traditional study quality criteria, such as participant or researcher blinding, are extremely difficult to implement. METHODS: We developed the Tool for the assEssment of Study qualiTy and reporting in EXercise (TESTEX) - a study quality and reporting assessment tool, designed specifically for use in exercise training studies. Our tool is a 15-point scale (5 points for study quality and 10 points for reporting) and addresses previously unmentioned quality assessment criteria specific to exercise training studies. RESULTS: There were no systematic differences between the summated TESTEX scores of each observer [H(2)=0.392, P=0.822]. There was a significant association between the summated TESTEX scores of the three observers, with almost perfect agreement between observers 1 and 2 [intra-class correlation coefficient (ICC)=0.93, 95% confidence interval (CI) 0.82-0.97, P<0.001], observers 1 and 3 (ICC= 0.96, 95% CI 0.89-0.98, P<0.001) and observers 2 and 3 (ICC=0.91, 95% CI 0.75-0.96, P<0.001). CONCLUSIONS: The TESTEX scale is a new, reliable tool, specific to exercise scientists, that facilitates a comprehensive review of exercise training trials.
INTRODUCTION: Several established tools are available to assess study quality and reporting of randomized controlled trials; however, these tools were designed with clinical intervention trials in mind. In exercise training intervention trials some of the traditional study quality criteria, such as participant or researcher blinding, are extremely difficult to implement. METHODS: We developed the Tool for the assEssment of Study qualiTy and reporting in EXercise (TESTEX) - a study quality and reporting assessment tool, designed specifically for use in exercise training studies. Our tool is a 15-point scale (5 points for study quality and 10 points for reporting) and addresses previously unmentioned quality assessment criteria specific to exercise training studies. RESULTS: There were no systematic differences between the summated TESTEX scores of each observer [H(2)=0.392, P=0.822]. There was a significant association between the summated TESTEX scores of the three observers, with almost perfect agreement between observers 1 and 2 [intra-class correlation coefficient (ICC)=0.93, 95% confidence interval (CI) 0.82-0.97, P<0.001], observers 1 and 3 (ICC= 0.96, 95% CI 0.89-0.98, P<0.001) and observers 2 and 3 (ICC=0.91, 95% CI 0.75-0.96, P<0.001). CONCLUSIONS: The TESTEX scale is a new, reliable tool, specific to exercise scientists, that facilitates a comprehensive review of exercise training trials.
Authors: Timothy B Davies; Derek L Tran; Clorinda M Hogan; G Gregory Haff; Christopher Latella Journal: Sports Med Date: 2021-01-21 Impact factor: 11.136
Authors: Rod S Taylor; Sarah Walker; Neil A Smart; Massimo F Piepoli; Fiona C Warren; Oriana Ciani; David Whellan; Christopher O'Connor; Steven J Keteyian; Andrew Coats; Constantinos H Davos; Hasnain M Dalal; Kathleen Dracup; Lorraine S Evangelista; Kate Jolly; Jonathan Myers; Birgitta B Nilsson; Claudio Passino; Miles D Witham; Gloria Y Yeh Journal: J Am Coll Cardiol Date: 2019-04-02 Impact factor: 24.094
Authors: Eduardo Caldas Costa; Jacqueline L Hay; Dustin S Kehler; Kevin F Boreskie; Rakesh C Arora; Daniel Umpierre; Andrea Szwajcer; Todd A Duhamel Journal: Sports Med Date: 2018-09 Impact factor: 11.136
Authors: Jodie D Inder; Deborah J Carlson; Gudrun Dieberg; James R McFarlane; Nicole Cl Hess; Neil A Smart Journal: Hypertens Res Date: 2015-10-15 Impact factor: 3.872
Authors: Ricardo Borges Viana; Claudio Andre Barbosa de Lira; João Pedro Araújo Naves; Victor Silveira Coswig; Fabrício Boscolo Del Vecchio; Rodrigo Ramirez-Campillo; Carlos Alexandre Vieira; Paulo Gentil Journal: Sports Med Date: 2018-09 Impact factor: 11.136